Cangene Closes Buy of Hemophilia Product Portfolio
Cangene Corp., a Winnipeg, Manitoba-based developer and manufacturer of immune therapeutics, has closed its acquisition of the hemophilia product portfolio of Inspiration Biopharmaceuticals Inc. Cambridge, Massachusetts-based Inspiration, which has recently undergone bankruptcy proceedings, was previously a portfolio company of US private equity firm Celtic Pharmaceutical Holdings LP. Celtic has estimated the aggregate consideration of the deal could exceed US$1 billion.
20 February 2013•7 mins read
